Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T...

Area of Science:

• Immunotherapy
• Oncology
• Cellular Therapy

Background:

• Chimeric antigen receptor (CAR) T cell therapy represents a significant advancement in cancer treatment, particularly for B-cell malignancies.
• However, its efficacy against solid tumors is limited due to the complex tumor microenvironment.
• This review synthesizes current knowledge on CAR T cell therapy, addressing its applications, challenges, and future potential.

Purpose of the Study:

• To review the structure, clinical applications, and adverse effects of CAR T cell therapy.
• To discuss challenges and controversies associated with CAR T cell therapy in both hematological and solid tumors.
• To explore novel engineering methods and future directions for developing next-generation CAR T cells.

Main Methods:

• Comprehensive literature review of finished and ongoing clinical trials.
• Analysis of current engineering strategies and modifications for CAR T cells.
• Discussion of challenges specific to solid tumors and proposed solutions.

Main Results:

• CAR T cell therapy has demonstrated remarkable success in hematological malignancies.
• Significant hurdles remain for solid tumor treatment, including tumor microenvironment interactions.
• Recent engineering advancements aim to create 'smarter' CAR T cells with enhanced potency and safety.

Conclusions:

• CAR T cell therapy holds immense potential but requires further optimization for broader application, especially against solid tumors.
• Future research should focus on innovative engineering approaches to overcome current limitations and improve therapeutic outcomes.
• Developing next-generation CAR T cells is crucial for enhancing efficacy and minimizing adverse effects in cancer treatment.